LIVE

€49.70 ▼−5.06%

/Ruby & Sapphire/Camerupt

Variants

STANDARD · Conviction 5/10

Camerupt

Ruby & Sapphire · #4 · Rare Holo

Graded

PSA 9€63.40

PSA 10€445.67

Composite

5.2

Verify externally — possibly staleEU 2% above US

Buy range€5.11 – €6.68Above market

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

5.2

SCORE / 10

Liquidity

9.3

Scarcity

9.9

Era potential

8.9

Friction

4.7

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 10.18%Total population

PSA 10

PSA 9

286

PSA 8

214

Total graded

766

Gem rate 10.18%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

The Ruby & Sapphire Camerupt (#4) currently trades at €8.00 in the raw market. Its 30-day price movement has appreciated (+2.5%). By market value it ranks #39 of 109 in Ruby & Sapphire — the 65th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated medium. Read together, a mid-tier ranking in Ruby & Sapphire alongside rising 30-day momentum frames where Camerupt sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.